company-logo

Molecure S.A., a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland. It is involved in the development of OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has completed phase I clinical trial for the treatment of idiopathic pulmonary fibrosis and sarcoidosis; YKL-40 program for the treatment of cancer and fibrosis; OATD-02 for the treatment of cancer; and Deubiquitinase program. The company was formerly known as OncoArendi Therapeutics S.A. and changed its name to Molecure S.A. in March 2022. Molecure S.A. was founded in 2012 and is headquartered in Warsaw, Poland.

Molecure Dividend Announcement

Molecure does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Molecure dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Molecure Dividend History

Molecure Dividend Yield

Molecure current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Molecure stock? Use our calculator to estimate your expected dividend yield:

Molecure Financial Ratios

P/E ratio-6.14
PEG ratio-1.35
P/B ratio2.12
ROE-26.46%
Payout ratio0.00%
Current ratio8.81
Quick ratio8.96
Cash Ratio8.34

Molecure Dividend FAQ

Does Molecure stock pay dividends?
Molecure does not currently pay dividends to its shareholders.
Has Molecure ever paid a dividend?
No, Molecure has no a history of paying dividends to its shareholders. Molecure is not known for its dividend payments.
Why doesn't Molecure pay dividends?
There are several potential reasons why Molecure would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Molecure ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Molecure has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Molecure a dividend aristocrat?
Molecure is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Molecure a dividend king?
Molecure is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Molecure a dividend stock?
No, Molecure is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Molecure stocks?
To buy Molecure you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Molecure stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.